相关实验视频
Updated: Jun 25, 2025
06:02
Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
Published on: July 26, 2011
36.7K
通过机器学习,hdWGCNA和细胞通信识别了阿尔茨海默病中的活性NK细胞亚型,并通过机器学习对诊断标记物进行选
Guobin Song1, Haoyang Wu2, Haiqing Chen2
1School of Stomatology, Southwest Medical University, Luzhou, China.
Current Alzheimer research
|May 29, 2024
概括
研究人员使用三个关键基因开发了阿尔茨海默病 (AD) 的诊断模型,帮助早期诊断和了解疾病的免疫环境.
科学领域:
- 神经科学和免疫学 神经科学和免疫学
- 生物信息学和计算生物学
背景情况:
- 阿尔茨海默病 (AD) 是一种严重的神经退行性疾病,其特征是粉样质斑块和神经纤维状结.
- 准确的早期诊断和生物标志物开发对于全球管理AD至关重要.
- 机器学习和生物信息学是识别AD生物标志物的重要工具.
研究的目的:
- 识别与阿尔茨海默病相关的细胞亚型和特定基因.
- 开发一种基于机器学习的AD诊断模型.
- 为了研究已识别的基因在AD免疫微环境中的作用.
主要方法:
- 单细胞数据分析以识别差异性细胞亚型.
- 机器学习算法 (LASSO,随机森林,SVM-RFE) 用于基因选.
- 后勤回归模型开发,PPI网络分析和无监督集群.
主要成果:
- 三个基因 (RPLP2,RPSA,RPL18A) 被确定与AD高度相关.
- 创建了一个诊断名录,并根据基因表达发现了三种AD亚型.
- 在C3亚型中,高基因表达与免疫细胞透和炎症相关.
结论:
- 使用关键基因建立了阿尔茨海默病的有价值的诊断模型.
- 这项研究强调了这些基因在塑造AD免疫环境中的重要作用.
- 这些发现为早期AD诊断和改善患者管理策略提供了洞察力.
关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.在 NK 细胞中, NK 细胞是最重要的.蜂聊天 蜂聊天诊断签名 诊断签名 签名hdWGCNANA 在线观看免疫细胞亚型的分布模式.机器学习是机器学习.一个单细胞RNA-seqq.更多相关视频
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
7.9K
10:02Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
Published on: May 28, 2017
26.8K
相关概念视频
01:26Alzheimer's Disease: Overview
465
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
465
01:22Alzheimer's Disease: Treatment
180
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
180